Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
RSV (Respiratory syncytial virus)
Children
Risk group
Americas
Clear all
Type of publications
NITAG documentation
(8)
Topics
Available to download in languages
Regions
Americas
(8)
Africa
(2)
Europe
(6)
South-East Asia
(1)
Western Pacific
(5)
Countries
Bolivia
(1)
Canada
(1)
Chile
(1)
United States of America
(5)
Diseases
COVID-19
(7)
RSV (Respiratory syncytial virus)
(1)
Hepatitis B
(1)
Human papillomavirus (HPV)
(1)
Influenza
(1)
Pneumococcal disease
(4)
Rotavirus
(7)
Vaccine topics
Target population
Children
(5)
Risk group
(3)
Adolescents
(2)
Adults
(6)
Healthcare workers
(6)
Newborn
(1)
Parents/caregivers
(1)
Publication date
2023
(1)
2022
(1)
2021
(3)
2020
(3)
8 results found
2023
∙
ACIP
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
2021
∙
Comité Nacional de Inmunización (CNI)
Vaccination, prevention against COVID in children under 12 years old in Bolivia
2021
∙
ACIP
COVID-19 Vaccines for Children
2021
∙
ACIP
Epidemiology of COVID-19 in Children and Teens
2020
∙
CAVEI
CAVEI provisional recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
ACIP
COVID-19 vaccine prioritization: Work Group considerations
2020
∙
ACIP, Nancy McClung
Epidemiology of Individuals at Increased Risk of COVID-19 Disease
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register